Actos Side Effects : Sometimes, in an alternative procedure/ lasers (high-energy light beams) are used to remove superficial TCC tumors. While this is slightly more comfortable than resection for you as a patient, the laser often destroys the tumor tissue, leaving nothing for pathologists to examine. The lack of pathology may limit your medical team’s ability to predict recurrence and target your follow-up plan.
If you have been diagnosed with a low-risk tumor, resection may be the only treatment recommended by your medical team. Or your team may recommend a course of intravesical therapy, too. Intravesical is a medical term meaning “within the bladder/’ Intravesical therapy, therefore, means that treatment – in this case a solution containing anti-cancer drugs – is placed directly in the bladder instead of being given to you as a pill to swallow or as an injection.
The treatment is given as a liquid poured through an ordinary urinary catheter, the same device that is usually used to drain urine from the bladder. In this case, the flow of fluid is reversed, with the medication being injected gently up through the catheter into the inside of the bladder. Think of it this way: Remember when you were a kid and filled balloons with water? If you imagine the bladder as that balloon, filled not with water but with liquid medication sloshing around inside, you’ll ‘have a good idea of how intravesical therapy works.
Intravesical therapy has been used for about 30 years as a preventive treatment to reduce the recurrence rate for superficial bladder cancer. It is believed that intravesical therapy works because it destroys cancer cells that may remain “floating” in the bladder after resection, thereby reducing the possibility of a recurrence. It also may be absorbed directly into any remaining tumor tissue, causing destruction of the tumor. There are two types of intravesical therapy, chemotherapy and immunotherapy, with numerous treatment options within each therapy group.
More information on Actos Side Effects
Your medical team will take a number of things into consideration when deciding which intravesical treatment option is best for you. Their goal is to balance the effectiveness of the treatment with possible side effects and long-term risks based on the type and seriousness of your cancer. Aggressive treatment options with possibly serious side effects may well be the right choice if you’re dealing with a type of cancer that has a high recurrence rate and often comes back in a more life- threatening form. On the other hand, if your cancer is low risk and has a lesser chance of recurring, a more conservative approach might be taken.
Regardless of whether you’re advised to take chemotherapy or immunotherapy both are administered the same way The procedure can be performed either at the hospital about one to seven days after your resection or in your doctor’s office if a series of weekly treatments is recommended. The timing depends somewhat on how extensive the resection has been.
First your doctor will numb your urethra with a topical gel and insert a disposable catheter, which wall be used to fill the bladder with the solution. The catheter is removed after your bladder is full, and you’ll be asked to concentrate on not passing urine for a time, holding the solution inside while you get up and move around. Walking, sitting, and standing while the solution is held in your bladder causes it to slosh around and completely coat inside the bladder walls. After an hour or so, you’ll void the solution just as you would pass urine. In most cases, you’ll be asked to minimize your fluid intake before the procedure so that your bladder won’t also be filling with urine that wall put additional pressure on your bladder.
The chemotherapy drugs that are used in this way include doxorubicin (brand name Adriamycin), epirubicin (Pharmorubidn), mitomycin C (Mutamydn), and occasionally thiotepa (Thioplex). Chemotherapy solutions have proved effective in reducing recurrence rates by about 30 percent. However, chemotherapy has little or no effect in preventing superficial cancer from progressing to a more serious stage. What this means is that chemotherapy will often stop the superficial cancer
Information from other sources on Actos Side Effects
Although BCG is highly effective, it also has some toxic side effects, and as such is used primarily as a treatment for patients with high-risk types of superficial bladder cancer and those who have had repeated recurrences or CIS. Side effects may include a burning sensation in the bladder as well as fatigue, chills, and fever. A prolonged high fever and general feeling of being ill may be a sign that the BCG bacteria have spread through the body. Because BCG is the bacterium that causes a type of tuberculosis, antibiotics used to treat tuberculosis are usually prescribed when an infection occurs shortly after BCG immunotherapy. Another type of immunotherapy is interferon.This is naturally produced in your body’s cells and works much as BCG does in stimulating your body to attack cancer cells in the bladder. Temporary side effects, which usually disappear once interferon therapy is stopped, include muscle and bone aches, fatigue, vomiting, and headaches.
In almost all cases, intravesical therapy (chemotherapy or immunotherapy) is most effective when the first dose is given 6 to 24 hours after resection. Sometimes a single dose is given as a prophylactic (preventative) measure and is not repeated. More commonly, you’ll have one dose immediately after resection and then five more treatments on a weekly basis in your doctor’s office. In some cases, if a large tumor has been resected, leaving a larger area of ulcerated bladder surface, intravesical chemotherapy will be delayed for a few days to prevent the drug’s being absorbed through the damaged surface lining of the bladder. Your doctor may recommend a follow-up cystoscopy after the intravesical treatments are completed.
Keep in mind that there are several types of superficial bladder cancer, some of which have a high risk of recurrence or progression to a more serious stage. Treatment options, including resection and intravesical therapy, are different for each person and depend upon each person’s circumstances, For example, you may start talking to someone in your urologist’s waiting room who has had great results and few side effects from a single dose of mitomycin C (MCC) chemotherapy. Even more impressive, he hasn’t had a recurrence since his diagnosis three years ago. You, on the other hand, are on your fourth BCG treatment, and each one leaves you feeling as if you have severe bladder irritation for several days afterwards. “No side effects and no recurrences” sounds like a better deal than what you’re experiencing. So why wasn’t MCC prescribed for you?
Our use of the term or terms Actos Side Effects is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
To keep up to date on Actos Side Effects visit our site often.